Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections

2005/02/18 by Jean-Hugues Dalle, Jean‐Hugues Dalle, José Menézes +7 · 27 citations
Immunology and Microbiology · Medicine · #Biology #CD8 #Cell #Cell adhesion #Cell biology #Cord blood #Cytotoxic T cell #Granzyme #Granzyme B #Haematopoiesis #Hematopoietic Stem Cell Transplantation #Immune Cell Function and Interaction #Immune system #Immunology #In vitro #Interleukin 12 #Interleukin 21 #Internal medicine #Lymphokine-activated killer cell #Medicine #Natural killer cell #Neural cell adhesion molecule #Perforin #Reproductive System and Pregnancy #Stem cell #Transplantation

paper · pdf · doi:10.1203/01.pdr.0000156501.55431.20

openalex publication_date 2005/02/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Cited by

• The double-edged sword role of natural Killer cells in Parkinson's disease
• Shaping immunity: the influence of the maternal gut bacteria on fetal immune development
• The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. [europepmc]
• Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. [europepmc]
• Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion. [europepmc]
• Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. [europepmc]
• TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy. [europepmc]
• Immune responses in neonates. [europepmc]
• Immunity to HIV in Early Life. [europepmc]
• Cord Blood as a Source of Natural Killer Cells. [europepmc]
• Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications. [europepmc]
• Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment. [europepmc]
• Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer. [europepmc]
• Tissue-resident Eomes + NK cells are the major innate lymphoid cell population in human infant intestine. [europepmc]
• Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile. [europepmc]
• Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells. [europepmc]
• Surface protein imputation from single cell transcriptomes by deep neural networks. [europepmc]
• You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy. [europepmc]
• Exploring the NK cell platform for cancer immunotherapy. [europepmc]
• Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer. [europepmc]
• Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity. [europepmc]
• Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future. [europepmc]
• Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies. [europepmc]
• Natural killer cells in antitumour adoptive cell immunotherapy. [europepmc]
• Allogeneic natural killer cell therapy. [europepmc]
• Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. [europepmc]
• CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. [europepmc]